Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 9/20 | 0.72 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 6/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Ethylhexanoic Acid SCHEMBL31730242 | 0.87 | CA2 (0.75) | CA2MAPK1CA1CYP3A4TSHR | |
| 2-Ethylhexanoic Acid SCHEMBL17453704 | 0.87 | CA2 (0.75) | CA2MAPK1CA1CYP3A4TSHR | |
| 2-Ethylhexanoic Acid SCHEMBL594231 | 0.87 | CA2 (0.88) | CA2MAPK1CA1CYP3A4TSHR | |
| 2-Ethylhexanoic Acid SCHEMBL3649881 | 0.87 | CA2 (0.96) | CA2MAPK1CA1CYP3A4TSHR | |
| SCHEMBL3839235 | 0.85 | CA2 (0.84) | CA2MAPK1CA1CYP3A4TSHR | |
| SCHEMBL22772366 | 0.85 | CA2 (0.77) | CA2MAPK1CA1CYP3A4TSHR | |
| SCHEMBL22772375 | 0.85 | CA2 (0.77) | CA2MAPK1CA1CYP3A4TSHR | |
| Lithium Ion SCHEMBL22772374 | 0.85 | CA2 (0.77) | CA2MAPK1CA1CYP3A4TSHR | |
| SCHEMBL10944798 | 0.85 | CA2 (0.77) | CA2MAPK1CA1CYP3A4TSHR | |
| SCHEMBL30685115 | 0.85 | CA2 (0.84) | CA2MAPK1CA1CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250027005-A1 | CARBODIIMIDE FOR USE AS AN ADDITIVE IN LUBRICANTS INTENDED FOR DRIVE DEVICE SYSTEMS FOR IMPROVED ELASTOMER COMPATIBILITY | TOTALENERGIES ONETECH (FR) | 2025-01-23 | — | — | US | disclosed |
| EP-4136202-B1 | A PHOSPHONIUM-BASED IONIC LIQUID AND ITS USE AS A LUBRICANT ADDITIVE | TOTALENERGIES ONETECH (FR) | 2024-06-26 | — | — | EP | disclosed |
| US-20230279307-A1 | A PHOSPHONIUM-BASED IONIC LIQUID AND ITS USE AS A LUBRICANT ADDITIVE | TOTALENERGIES ONETECH (FR) | 2023-09-07 | — | — | US | disclosed |
| EP-4136202-A1 | A PHOSPHONIUM-BASED IONIC LIQUID AND ITS USE AS A LUBRICANT ADDITIVE | TOTALENERGIES ONETECH (FR) | 2023-02-22 | — | — | EP | disclosed |
| CN-115605564-A | Phosphonium-based ionic liquids and their use as lubricant additives | 道达尔能量联动技术公司（FR） | 2023-01-13 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230279307-A1 | A PHOSPHONIUM-BASED IONIC LIQUID AND ITS USE AS A LUBRICANT ADDITIVE | PHOSPHO1, PIK3CG, PIK3CD | CA2 412/4885MAPK1 631/4885CA1 93/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.